Scientist and MD in Neurooncology | Science policy advisor | sports & culture enthusiast Neurology Clinic, Heidelberg University; Health & Life Science Alliance; Neurooncology, DKFZ; German Science and Humanities Councilhttps://bsky.app/profile/wickwolfgang.bsky.socialhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3m4i7g3qses2uHerzlichen Dank an das Team und Minister Blume! [contains quote post or other embedded content]31 Oct 2025 09:53 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3m4i7g3qses2uhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3m3uii5eduk22Autumn in #Heidelberg. We are excited to welcome the brightest scientists in Neurooncology at the 8th Harvard Heidelberg Alliance in #Neurooncology! @dkfz.bsky.social @uniheidelberg.bsky.social23 Oct 2025 13:42 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3m3uii5eduk22https://bsky.app/profile/wickwolfgang.bsky.social/post/3m2susukhac2iCongratulations Dirk! I am proud of your achievement and very grateful for your work. #UNITE-GBM #HeidelbergUniversity [contains quote post or other embedded content]10 Oct 2025 04:53 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3m2susukhac2ihttps://bsky.app/profile/wickwolfgang.bsky.social/post/3lydmznt2ck2lWe need to find ways in help patients with MGMT non-hypermethylated #glioblastoma to get molecular testing and accordingly basey therapies alteady for primary treatment.08 Sep 2025 16:33 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lydmznt2ck2lhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3lydmvo3qec2lN2M2/NOA-20 - Of the five drugs tested, temsirolimus showed positive results. - Molecular testing works for primary therapy. - The study design allows for swift testing suitable cancer drugs. - Temozolomide is not active in MGMT non-hypermethylated glioblastoma Full text at rdcu.be/eEicj08 Sep 2025 16:31 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lydmvo3qec2lhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3lydmf3nqfc2lNOA Researchers from 13 German sites led by a team from @uniheidelberg.bsky.social @Universitätsklinikum Heidelberg (UKHD) & @dkfz.bsky.social have successfully completed the multicenter study “NCT Neuro Master Match (N2M2)”. https://rdcu.be/eEicj08 Sep 2025 16:21 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lydmf3nqfc2lhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3lfwjq5tvxs2yExciting novel molecular targets in this developing area! [contains quote post or other embedded content]17 Jan 2025 09:56 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lfwjq5tvxs2yhttps://bsky.app/profile/wickwolfgang.bsky.social/post/3ld4qqws3dc26🎉Es ist ein Riesenprivileg, wenn man mit so leistungsstarken und kreativen Wissenschaftler:innen wie @svenjatetzlaff.bsky.social und @venkataramanilab.bsky.social zusammenarbeiten darf. Der Schritt pathologische Netzwerke in Hirntumoren als Routen für Therapie zu explorieren,ist hochinnovativ. [contains quote post or other embedded content]12 Dec 2024 17:02 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3ld4qqws3dc26https://bsky.app/profile/wickwolfgang.bsky.social/post/3lbwpgnckks24The 🎉selection by Newsweek as one of the 🏆World's Best Hospitals and the inclusion of individual departments in World's Best Specialized Hospitals 2024 🏆 are recognition for Heidelberg University Hospital (UKHD) and a new incentive for the joint process.27 Nov 2024 13:57 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lbwpgnckks24https://bsky.app/profile/wickwolfgang.bsky.social/post/3lbwpgg4ah224Following the Health + Life Science Alliance for fundamental and socially relevant research, we want to take the next step towards medical specialization and differentiation together with the University Medical Center Mannheim.27 Nov 2024 13:57 +0000at://did:plc:b7ukoomnbvdhrnc36pvbgoci/app.bsky.feed.post/3lbwpgg4ah224